Call for abstracts

Abstract submission is now closed

Thank you very much for your contribution.



The only way to submit your abstract is by using the link posted in this symposium Abstract Section (please use the link at the end of this page). Once your abstract has been submitted you will receive a confirmation email indicating that all the information has been received correctly. If you do not receive this confirmation, then please contact the Technical Secretariat.


The deadline to submit your abstract is 15th September 2023.
An acceptance/rejection notification will be sent via email with all the necessary presentation details by 20th September 2023.


These should include educational elements such as the problem or difficulty, how to avoid and resolve it.


You can select within four different topics:

– Challenging cases in PAD therapy

– Challenging cases in Aorta and its branches

– Challenging cases in Venous

– Challenging cases in Vascular Nursing


When submitting your abstract, you should select your preference.

The 3 best abstracts for each topic will be chosen for presentation.

The best Challenging Case on each topic chosen by the Moderators will be awarded with the prize of 2,500€.


SITE Barcelona 2023 e-POSTERS

The best poster chosen by the participants via voting system on-site will be awarded with the prize of 1,500€.



All abstracts must be submitted through the official link posted at the end of this page.

The deadline to submit your abstract is 15th September 2023.

The maximum number of authors permitted is 6 (1 author plus 5 co-authors).

One of the authors must be registered in the Symposium.

The title should be in capitals and extend to no more than two lines. Avoid abbreviations.


Organize the text following these sections:

  • Introduction
  • Objectives
  • Material used
  • Methodology used
  • Results of the study
  • Conclusions of the study

SITE Barcelona 2023 on-demand content  is  available online.

You can already access a wide range of session replays and recordings. Access here.